|3.59||+0.0400||+1.13%||Vol 180.34K||1Y Perf -76.17%|
|May 13th, 2022 16:00 DELAYED|
|- -%||- -|
|Target Price||17.00||Analyst Rating||Moderate Buy 1.67|
|Potential %||373.54||Finscreener Ranking||★★★+ 51.70|
|Insiders Trans % 3/6/12 mo.||-/-9/-57||Value Ranking||★★★+ 52.88|
|Insiders Value % 3/6/12 mo.||-/-8/-66||Growth Ranking||★★★ 52.38|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-13/-54||Income Ranking||— -|
|Price Range Ratio 52W %||4.23||Earnings Rating||Strong Sell|
|Market Cap||90.40M||Earnings Date||11th May 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.10|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||193.45K|
|Avg. Monthly Volume||232.94K|
|Avg. Quarterly Volume||191.90K|
iCad Inc. (NASDAQ: ICAD) stock closed at 3.59 per share at the end of the most recent trading day (a 1.13% change compared to the prior day closing price) with a volume of 180.34K shares and market capitalization of 90.40M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 138 people. iCad Inc. CEO is Michael Klein.
The one-year performance of iCad Inc. stock is -76.17%, while year-to-date (YTD) performance is -50.14%. ICAD stock has a five-year performance of -27.77%. Its 52-week range is between 2.91 and 19, which gives ICAD stock a 52-week price range ratio of 4.23%
iCad Inc. currently has a PE ratio of -8.20, a price-to-book (PB) ratio of 2.00, a price-to-sale (PS) ratio of 3.63, a price to cashflow ratio of 21.00, a PEG ratio of 2.32, a ROA of -19.10%, a ROC of -25.57% and a ROE of -29.19%. The company’s profit margin is -38.42%, its EBITDA margin is -31.40%, and its revenue ttm is $24.99 Million , which makes it $0.99 revenue per share.
Of the last four earnings reports from iCad Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. iCad Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for iCad Inc. is Moderate Buy (1.67), with a target price of $17, which is +373.54% compared to the current price. The earnings rating for iCad Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
iCad Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
iCad Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.08, ATR14 : 0.28, CCI20 : 40.40, Chaikin Money Flow : -0.03, MACD : -0.10, Money Flow Index : 50.59, ROC : -2.71, RSI : 48.51, STOCH (14,3) : 49.28, STOCH RSI : 0.85, UO : 49.54, Williams %R : -50.72), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of iCad Inc. in the last 12-months were: Andrew H. Sassine (Sold 120 000 shares of value $1 009 500 ), Charles Ross Carter (Buy at a value of $49 350), Jonathan Go (Option Excercise at a value of $94 500), Jonathan Go (Sold 8 750 shares of value $95 025 ), Michael Klein (Buy at a value of $99 446), Nathaniel Dalton (Buy at a value of $49 956), Stacey Stevens (Buy at a value of $104 927), Stacey Stevens (Option Excercise at a value of $38 068), Stacey Stevens (Sold 22 735 shares of value $407 810 ), Susan Wood (Buy at a value of $10 965)
Tue, 01 Mar 2022 06:05 GMT Analysts Top Technology Picks: iCAD (ICAD), PubMatic (PUBM)- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.